PPARδ comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-08-31. Numbers and descriptions here follow the published literature rather than marketing material.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a metabolic modulator. |
| Approved medical use | None in major jurisdictions | Not a registered drug. |
| Common test matrix | Urine | Most anti-doping samples use urine. |
| Typical detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Reference standard storage | -20 °C, desiccated | Typical for analytical standards. |
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Public healthcare in Hong Kong is recognized for its high-quality medical outcomes. The territory has the highest life expectancy in the world at 85.9 years. Hong Kong has one of the lowest infant mortality rates in the world, with recent estimates placing it around 1.7 to 2.5 deaths per 1,000 live births. However, the public system also faces challenges, including high patient volumes, overcrowding in emergency departments, and long wait times for specialist appointments and elective procedures. Healthcare in Hong Kong is provided through two categories, consisting of public and private hospitals. While private hospital services cater to patients seeking shorter wait times and personalized care, the majority of the population relies on the extensive public healthcare system. Public hospitals and clinics are heavily subsidized by the government, ensuring affordable access to a wide range of medical services. Hong Kong's healthcare system is managed primarily by the Hospital Authority, which was established in 1990 to oversee and operate all public hospitals in the region. The system is organized into seven geographic clusters that group hospitals and associated healthcare facilities based on their distribution across the territory. As of 2026, Hong Kong has a total of 42 public hospitals and 11 private hospitals.
is the transmittance of that material. Absorbance is a dimensionless quantity. Nevertheless, the absorbance unit or AU is commonly used in ultraviolet–visible spectroscopy and its high-performance liquid chromatography applications, often in derived units such as the milli-absorbance unit (mAU) or milli-absorbance unit-minutes (mAU×min), a unit of absorbance integrated over time. Absorbance is related to optical depth by
== Outcomes == Outcomes of muscle atrophy depend on the underlying cause and the health of the patient. Immobility or bed rest in populations predisposed to muscle atrophy, such as the elderly or those with disease states that commonly cause cachexia, can cause dramatic muscle atrophy and impact on functional outcomes. In the elderly, this often leads to decreased biological reserve and increased vulnerability to stressors known as the "frailty syndrome." Loss of lean body mass is also associated with increased risk of infection, decreased immunity, and poor wound healing. The weakness that accompanies muscle atrophy leads to higher risk of falls, fractures, physical disability, need for institutional care, reduced quality of life, increased mortality, and increased healthcare costs.
==== 2500–2599 ==== Trade Union Reform and Employment Rights Act 1993 (Commencement No. 2 and Transitional Provisions) Order 1993 (S.I. 1993/2503) Combined Probation Areas (Dorset) Order 1993 (S.I. 1993/2512) Teachers' (Superannuation and Compensation for Premature Retirement) (Scotland) Amendment Regulations 1993 (S.I. 1993/2513) Coal Industry Act 1992 (Commencement) Order 1993 (S.I. 1993/2514) Export of Goods (Control) (Amendment No. 5) Order 1993 (S.I. 1993/2515) Friendly Societies (Qualifications of Actuaries No.2) Regulations 1993 (S.I. 1993/2518) Friendly Societies (Amendment) Regulations 1993 (S.I. 1993/2519) Friendly Societies (Insurance Business No. 2) Regulations 1993 (S.I. 1993/2520) Friendly Societies (Authorisation No. 2) Regulations 1993 (S.I. 1993/2521) A11 Trunk Road (Roudham Heath to Attleborough Improvement and Slip Roads) Order 1993 (S.I. 1993/2524) A11 Trunk Road (Roudham Heath to Attleborough Improvement) (Detrunking) Order 1993 (S.I. 1993/2525) Protection of Wrecks (Designation No. 2) Order 1993 (S.I. 1993/2526) Police (Amendment) (No. 4) Regulations 1993 (S.I. 1993/2527) Police Cadets (Amendment) Regulations 1993 (S.I. 1993/2528) Fodder Plant Seeds (Amendment) Regulations 1993 (S.I. 1993/2529) Seeds (Registration, Licensing and Enforcement) (Amendment) Regulations 1993 (S.I. 1993/2530) Local Government Superannuation (Maternity Absence) Regulations 1993 (S.I. 1993/2531) Sea Fisheries Districts (Variation) Order 1993 (S.I. 1993/2532) Suppression of Terrorism Act 1978 (Application of Provisions) (India) Order 1993 (S.I.
Sources: en.wikipedia.org
=== Innovations === The initial stages of the Industrial Revolution had much to do with larger military forces—it became easy to mass-produce weapons and thus to equip larger forces. Britain was the largest single manufacturer of armaments in this period. It supplied most of the weapons used by the coalition powers throughout the conflicts. France produced the second-largest total of armaments, equipping its own huge forces as well as those of the Confederation of the Rhine and other allies. Napoleon showed innovative tendencies in his use of mobility to offset numerical disadvantages, as demonstrated in the rout of the Austro–Russian forces in 1805 in the Battle of Austerlitz. The French Army redefined the role of artillery, forming independent, mobile units, as opposed to the previous tradition of attaching artillery pieces in support of troops. The semaphore system had allowed the French War-Minister, Carnot, to communicate with French forces on the frontiers throughout the 1790s. The French continued to use this system throughout the Napoleonic wars. Aerial surveillance was used for the first time when the French used a hot-air balloon to survey coalition positions before the Battle of Fleurus, on 26 June 1794.
=== MeSH D12.644.641 – peptides, cyclic === MeSH D12.644.641.040 – alamethicin MeSH D12.644.641.050 – amanitins MeSH D12.644.641.075 – bacitracin MeSH D12.644.641.142 – capreomycin sulfate MeSH D12.644.641.235 – cyclosporins MeSH D12.644.641.235.300 – cyclosporine MeSH D12.644.641.243 – cyclotides MeSH D12.644.641.252 – dactinomycin MeSH D12.644.641.270 – daptomycin MeSH D12.644.641.297 – depsipeptides MeSH D12.644.641.297.500 – valinomycin MeSH D12.644.641.325 – echinomycin MeSH D12.644.641.380 – ferrichrome MeSH D12.644.641.515 – mycobacillin MeSH D12.644.641.548 – nanotubes, peptide MeSH D12.644.641.582 – nisin MeSH D12.644.641.650 – octreotide MeSH D12.644.641.735 – phalloidine MeSH D12.644.641.780 – polymyxins MeSH D12.644.641.780.110 – colistin MeSH D12.644.641.780.750 – polymyxin b MeSH D12.644.641.802 – streptogramins MeSH D12.644.641.802.249 – mikamycin MeSH D12.644.641.802.374 – pristinamycin MeSH D12.644.641.802.500 – streptogramin group a MeSH D12.644.641.802.500.500 – streptogramin a MeSH D12.644.641.802.750 – streptogramin group b MeSH D12.644.641.802.750.500 – streptogramin b MeSH D12.644.641.802.812 – vernamycin b MeSH D12.644.641.802.875 – virginiamycin MeSH D12.644.641.802.875.500 – streptogramin a MeSH D12.644.641.825 – thiostrepton MeSH D12.644.641.875 – viomycin MeSH D12.644.641.875.250 – enviomycin
=== Based on evolutionary phylogeny === An up-to-date classification of protease evolutionary superfamilies is found in the MEROPS database. In this database, proteases are classified firstly by 'clan' (superfamily) based on structure, mechanism and catalytic residue order (e.g. the PA clan where P indicates a mixture of nucleophile families). Within each 'clan', proteases are classified into families based on sequence similarity (e.g. the S1 and C3 families within the PA clan). Each family may contain many hundreds of related proteases (e.g. trypsin, elastase, thrombin and streptogrisin within the S1 family). Currently more than 50 clans are known, each indicating an independent evolutionary origin of proteolysis.
A major center of slave trade to the Middle east was central Asia, where the Bukhara slave trade had supplied slaves to the Middle East for thousands of years from antiquity until the 1870s. A slave market for captured Russian and Persian slaves was the Khivan slave trade centred in the Central Asian khanate of Khiva. In the early 1840s, the population of the Uzbek states of Bukhara and Khiva included about 900,000 slaves. By 1870, chattel slavery had been at least formally banned in most areas of the world, with the exception of Muslim lands in Caucasus, Africa, and the Persian Gulf. While slavery was by the 1870s viewed as morally unacceptable in the West, slavery was not considered to be immoral in the Muslim world since it was an institution recognized (halal) in the Quran and morally justified under the guise of warfare against non-Muslims (kafir of Dar al-Harb), and non-Muslims were kidnapped and enslaved by Muslims around the Muslim world: in the Balkans, the Caucasus, the Baluchistan, India, South West Asia and the Philippines. Slaves where marched in shackles to the coasts of Sudan, Ethiopia and Somali, placed upon dhows and trafficked across the Indian Ocean to the Gulf of Aden, or across the Red Sea to Arabia and Aden, with weak slaves being thrown in the sea; or across the Sahara desert via the Trans-Saharan slave trade to the Nile, while dying from exposure and swollen feet.
== Artificial intelligence readiness == The Government Artificial Intelligence Readiness Index 2019 seeks to answer the question, "how well placed are national governments to take advantage of the benefits of AI in their operations and delivery of public services?" In its survey of 194 nations, research firm Oxford Insights conducted research on behalf of Canada's International Development Research Centre (IDRC). Thailand ranked 56 of 194 nations. Other ASEAN members were ranked: Singapore, 1; Malaysia, 22; Philippines, 50; Indonesia, 57; Vietnam, 70; Brunei, 121; Cambodia, 124; Laos, 137; and Myanmar, 159.
Sources: en.wikipedia.org
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.
Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.
No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.